SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.29-0.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (13347)1/15/1998 12:37:00 PM
From: Roy Glen  Read Replies (1) of 32384
 
Henry, I am interested in the discussion you were having with Andrew and V1 about whether or not retinoids can be effective treatments for solid tumors. Given that one of the main advantages of the retinoids is their low toxicity, would it not make sense to pair them with a cancer vaccine? Biomira has reported very encouraging phase 11 results against breast cancer with a carbohydrate cancer vaccine that also has low toxicity. Even if the pair only matched the effectiveness of chemotherapy, the quality of life benefits would be huge.
I am sure other companies are working in the same area. Any thoughts?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext